Alprostadil

前列地尔

Report date: 2026/03/30 17:02:26

Base Information

Drug NameAlprostadil
Drug Alias Name前列腺素E1AlprostadilumInhaled PGE1前列地药Prostaglandin E1 +[29] 
ClassificationSmall molecules
Mechanisms of ActionProstaglandin agonists
TargetsProstaglandin
Therapy Area/IndicationsInfant, Newborn, DiseasesThromboembolismArterial Occlusive Diseases +[16] 
Global Approved IndicationsArterial Occlusive DiseasesHeart Defects, Congenital
Approved Indications in ChinaArterial Occlusive Diseases
Original Approved Country/TerritoryUnited States
Original Approved Date1981/10/16
Country/TerritoryUnited StatesAustriaGermany +[4] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesEndo Operations LtdPfizer IncBiopeutics Co Ltd +[5] 
Inactive CompaniesVivus LLCEunice Kennedy Shriver National Institute Of Child Health And Human DevelopmentUcb Pharma +[7] 
Active IndicationsThromboembolismArterial Occlusive DiseasesHeart Failure +[6] 
Inactive IndicationsInfant, Newborn, DiseasesCardiovascular DiseasesObstetric Labor, Premature +[10] 

Other Information

ATC CodeC01EA01G04BE01
Related LinksWikipediaDrugBankKEGG